714 PAIN AND QUALITY OF LIFE (QOL) ANALYSES FROM THE PHASE 3 RANDOMIZED ALSYMPCA STUDY WITH RADIUM-223 DICHLORIDE (RA-223) IN CASTRATION-RESISTANT PROSTATE CANCER (CRPC) PATIENTS WITH BONE METASTASES
Authors:
- 30 April 2013
- journal article
- abstracts
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 189 (4S)